Skin Disease Articles & Analysis
28 news found
The multi-target research and development partnership will focus on severe skin diseases The collaboration leverages etherna’s proprietary mRNA and lipid nanoparticle (LNP) technology with Almirall’s expertise in the dermatology space In addition to upfront and technology access payments, etherna is eligible to receive €300 million in ...
ByeTheRNA
In recent years, the 1064 Q switched Nd YAG laser has been widely used in clinical practice, using selective photothermal action as the theoretical basis for the non-invasive treatment of pigment-increasing dermatoses by selectively destroying skin melanocytes. Bvlaser is a Q switched ND YAG laser tattoo removal machine manufacturer, we have portable ND YAG laser for sale. ...
Spot removal, melanin removal The picosecond aesthetic laser uses a very short pulse output, using shock waves to shatter the black particles of material deposition, to achieve the effect of removing spots and melanin. 2. Skin rejuvenation The picosecond laser also activates the skin's overall renewal mechanism without harming the skin, ...
Selective photothermolysis The theoretical basis of IPL skin treatment machine of skin diseases is the principle of selective photothermal action. Because IPL has a broad spectrum, it can cover multiple absorption peaks of various pigment groups such as melanin, oxidized hemoglobin, and water. In the treatment of vascular skin ...
There is increasing use of alpha hydroxy acids for skin rejuvenation as well as the use of vitamin C in topical formulations as an antioxidant. ...
CO2 fractional laser resurfacing machine treatment can quickly improve skin texture, firm skin, improve large pores, and make skin smooth and tender like water. ...
Part of normal skin can be protected and skin recovery can be accelerated. ▶It can quickly improve skin texture, firm skin, improve large pores, and make skin as smooth and delicate as water. ...
The role of CE Certification picosecond laser machine is mainly to removal pigmentation spots, improve skin tone, and make the skin firmer. At the same time, it can also remove small wrinkles and achieve the purpose of skin rejuvenation. ...
Preliminary squamous cell carcinomas such as actinic keratosis (AK) have been among the most common skin diseases treated by dermatologists. Furthermore, a significant increase in actinic keratoses has been observed in the last decade. ...
The pharmaceutical company has been developing and marketing generics for prescription medicines in the field of skin diseases. In addition, the company also has a patent-protected originator product in the same field. By investing in DERMAGO GmbH, the investors had the opportunity to make investments in three pharmaceutical companies at the same time with ...
Epidermolysis bullosa, or EB, is a group of rare genetic skin diseases characterized by fragile skin that can lead to extensive blistering and wounding. ...
“We are very pleased with the updated preliminary results from the Phase 1/2 STAAR study and believe that isaralgagene civaparvovec gene therapy has the potential to be a compelling treatment option for patients with Fabry disease, who currently have a burdensome standard of care that requires regular and lifelong intravenous treatment, and that in many cases doesn’t ...
BOSTON--(BUSINESS WIRE)-- DermBiont, Inc., a clinical-stage biotechnology company developing targeted topical therapeutics that address the root causes of skin diseases, announced today that it has raised a $28 million Series A2 financing in parallel with the acquisition of clinical-stage biotechnology company Chromaderm, which is developing a topical inhibitor ...
In 2019 the plasma care® was approved for the treatment of chronic wounds, in 2021 the plasma derma care® for the treatment of skin diseases induced by bacteria and fungi. The plasma intensive care, a device for reducing the bacterial load in the oropharynx in ventilated intensive care patients, is currently in the approval process. ...
“There is significant unmet need in Fabry disease, a progressive and challenging condition that is currently treated with frequent burdensome infusions that do not adequately address the underlying disease,” said Rob Schott, M.D., M.P.H, F.A.C.C, Head of Development at Sangamo. ...
CAPs have been proven to be effective in wound healing, skin diseases, antifungal treatments and have also been reported to induce inactivation of viruses by several researchers around the world. ...
Modena, 23 April 2021 – The European Research Council (ERC) yesterday announced the winners of the 2020 Advanced Grants. The grants, worth a total of €507 million, will support 209 researchers across Europe. Eight projects were won by researchers working in Italy, including the project presented by Michele De Luca, Director of the “Stefano Ferrari” Centre for Regenerative ...
DermBiont's Phase 2a trial was primarily designed as a safety and tolerability study with a secondary endpoint to demonstrate that DBI-001 could have a favorable effect on the skin microbiome of atopic dermatitis patients. A single topical application of investigational drug product showed DBI-001 to be well tolerated with no safety issues while also resulting in decreased ...
The application of DBI-001 positively shifts the microbial ecology of the human skin at treated sites, leading to a positive state of symbiosis in patients' skin microbiome. ...
Michelson Diagnostics Ltd, manufacturer of the world-leading VivoSight OCT skin imaging and measurement system, has teamed up with AI specialists Manchester Imaging Ltd, to aid dermatologists in the fight against skin cancer and other skin diseases. Michelson’s VivoSight Dx OCT scanner is used by trained dermatologists in ...